Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harnish Patel

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Plos One|November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trialTufail Bashir, Marcus Achison, Simon Adamson, et al.
Plos One|October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trialChristos Rossios, Tufail Bashir, Marcus Achison, et al.
Plos One|August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trialAlvin Shrestha, Tufail Bashir, Marcus Achison, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 17, 2022
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial, Marcus Achison, Simon Adamson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Plos One|November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trialTufail Bashir, Marcus Achison, Simon Adamson, et al.
Plos One|October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trialChristos Rossios, Tufail Bashir, Marcus Achison, et al.
Plos One|August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trialAlvin Shrestha, Tufail Bashir, Marcus Achison, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 17, 2022
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial, Marcus Achison, Simon Adamson, et al.
Pageof 2